Commentary: Patterns of treatment discontinuation in neovascular age-related macular degeneration
- PMID: 35647984
- PMCID: PMC9359245
- DOI: 10.4103/ijo.IJO_825_22
Commentary: Patterns of treatment discontinuation in neovascular age-related macular degeneration
Conflict of interest statement
None
Comment on
-
Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.Indian J Ophthalmol. 2022 Jun;70(6):2065-2070. doi: 10.4103/ijo.IJO_3066_21. Indian J Ophthalmol. 2022. PMID: 35647983 Free PMC article.
References
-
- Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration:Relative roles of genetic and environmental influences. Arch Ophthalmol. 2005;123:321–7. - PubMed
-
- Ferris FL, Fine SL, Hyman L. Age related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640–2. - PubMed
-
- GBD 2019 Blindness and Vision Impairment Collaborators on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study, Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020:The right to sight:An analysis for the global burden of disease study. Lancet Glob Health. 2021;9:e144–60. - PMC - PubMed
-
- Shrivastava RK, Jose R, Rammamoorthy K, Bhushan B, Tiwari AK, Malik KP, et al. NPCB:Achievements and targets. NPCB India. 2006;1:5–6.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
